Composition
- Active ingredients
- CEPHRADINE 125MG/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEPHRADINE 125MG/5ML · For suspensionANDA062693-001 · Discontinued
- CEPHRADINE 250MG/5ML · For suspensionANDA062693-002 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062762-001 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062762-002 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062851-001 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062850-001 · Discontinued
- CEPHRADINE 250MG/5ML · For suspensionANDA062859-001 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062813-001 · Discontinued
- CEPHRADINE 500MG · CapsuleANDA062813-002 · Discontinued
- CEPHRADINE 125MG/5ML · For suspensionThis page
- CEPHRADINE 500MG · CapsuleANDA062683-002 · Discontinued
- CEPHRADINE 250MG · CapsuleANDA062683-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062858.
At a glance
- Brand name
- Cephradine
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Barr
- Status
- Discontinued
- FDA approval
- 19 May 1988
- Application
- ANDA062858-001